KRM Ayurveda last traded at ₹266.00 (2026-10-13). Over the past month the stock moved -9.5%, three months the stock moved +7.3%. Its closing range over 52 weeks is ₹160.55 – ₹317.30, with the latest close 16.2% below the high.
Closing prices up to 2026-10-13.
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India.[1]
Business Profile[1] KRM Ayurveda Limited operates an integrated Ayurvedic healthcare platform combining multispecialty hospitals, clinics, teleconsultation services, and in-house Ayurvedic medicine manufacturing.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 32.32 | 12.02 | 37.19 | 9.08 | 4.27 |
| Mar 2026 | 32.21 | 10.98 | 34.09 | 7.81 | 3.67 |
| Jun 2025 | 24.67 | 6.21 | 25.17 | 4.05 | 270.00 |
In the latest year (Mar 2026), KRM Ayurveda reported sales of ₹102.00 crore (+32.5%) and net profit of ₹20.00 crore (+66.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 102.00 | 30.00 | 30.00 | 20.00 | 9.46 |
| Mar 2025 | 77.00 | 19.00 | 25.00 | 12.00 | 806.67 |
| Mar 2024 | 67.00 | 8.00 | 11.00 | 3.00 | 2,273.33 |
| Mar 2023 | 89.00 | 11.00 | 13.00 | 8.00 | 5,066.67 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | -24.7% | +14.9% | +32.5% |
| Operating profit growth | -27.3% | +137.5% | +57.9% |
| Net profit growth | -62.5% | +300.0% | +66.7% |
| EPS growth | -55.1% | -64.5% | -98.8% |
| OPM % | 11.0% | 25.0% | 30.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for KRM Ayurveda.
Get Free AI Stock Analysis FREE →KRM Ayurveda establishes MSS Hospital in New Delhi with 23 beds - scanx.trade
KRM Ayurveda Schedules FY26 Investor Presentation; Reports ₹10,169.07 Lakh Revenue with 32.84% YoY Growth - scanx.trade
KRM Ayurveda Schedules FY26 Investor Presentation; Reports ₹10,169.07 Lakh Revenue with 32.84% YoY Growth - scanx.trade
KRM Ayurveda Schedules FY26 Investor Presentation; Reports ₹10,169.07 Lakh Revenue with 32.84% YoY Growth - scanx.trade
KRM Ayurveda shares were last quoted at ₹266.00 (-2.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
KRM Ayurveda has a price-to-earnings (P/E) ratio of 25.34 and a price-to-book (P/B) ratio of 5.13. The industry P/E is 53.33.
The 52-week high of KRM Ayurveda is ₹343.95 and the 52-week low is ₹156.15.
The market capitalisation of KRM Ayurveda is about ₹635.06 crore.
This page is for information and is not investment advice. As per the data shown here, KRM Ayurveda has a 3-year ROE of 37.00%, 3-year profit growth of 38.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 69.15% of KRM Ayurveda.
KRM Ayurveda belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z